Vermont H0202 aims to increase transparency in prescription drug costs and spending.
Vermont H0202 mandates pharmacies to inform customers about their price options for prescription drugs. It requires hospitals participating in the federal 340B drug pricing program to report annually to the Green Mountain Care Board. Health insurers must also report annually to covered individuals about their prescription drug spending. The bill aims to ensure consumers are aware of the best available prices and the actual costs incurred by their health insurance plans.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.